Source: Virtual Congress 2021 – Pneumonia



Rating:

Share or cite this content

Citations should be made in the following way:
L. Serrano Fernandez (Barakaldo (Bizkaia), Spain), L. Ruiz Iturriaga (Barakaldo (Bizkaia), Spain), P. España Yandiola (Galdakao (Bizkaia), Spain), R. Mendez Ocaña (Valencia, Spain), S. Perez Fernandez (Barakaldo (Bizkaia), Spain), E. Tabernero Huget (Barakaldo (Bizkaia), Spain), A. Uranga Echeverria (Galdakao (Bizkaia), Spain), P. Gonzalez Jimenez (Valencia, Spain), P. Garcia Hontoria (Galdakao (Bizkaia), Spain), R. Menendez Villanueva (Valencia, Spain), R. Zalacain Jorge (Barakaldo (Bizkaia), Spain). Bacteraemic pneumococcal pneumonia and SARS-CoV-2 pneumonia: differences and similarities. 1750

Member's Comments

No comment yet.

Related content which might interest you: Prognostic score systems and community-acquired bacteraemic pneumococcal pneumonia Source: Eur Respir J 2006 Oct 01;28(4):816-823 Year: 2006 Absence of leukocytosis in bacteremic pneumococcal pneumonia Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia Year: 2009 Changes in pathogens and pneumococcal serotypes causing community-acquired pneumonia in The Netherlands Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis   Year: 2017 Influence of pneumococcal serotype group on outcome in adults with bacteraemic pneumonia Source: Eur Respir J 2010; 36: 1073-1079 Year: 2010 Relation between bacteremia and septic shock in patients with pneumococcal community-acquired pneumonia Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013 Sepsis severity predicts outcome in community-acquired pneumococcal pneumonia Source: Eur Respir J 2007; 30: 517-524 Year: 2007 The comparison of hospitalized healthcare-associated pneumonia with community-acquired pneumonia patients Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients Year: 2010 Mixed community-acquired pneumonia in hospitalised patients Source: Eur Respir J 2006; 27: 795-800 Year: 2006 Complicated pneumococcal pneumonia in adults Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia Year: 2009 Risk factors for respiratory failure in pneumococcal pneumonia: the importance of pneumococcal serotypes Source: Eur Respir J 2014; 43: 545-553 Year: 2013 Epidemiology of community-acquired pneumonia and nosocomial pneumonia Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections Year: 2006 Bacteremic vs. non-bacteremic pneumococcal pneumonia in immunocompetent patients: Predictive and prognostic factors Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016 Evolution of antimicrobial resistance trends in the last five years in patients with bacteremic Pneumococcal community-acquired pneumonia (CAP-SP) Source: Eur Respir J 2005; 26: Suppl. 49, 639s Year: 2005 The pathophysiology of pneumococcal pneumonia Source: Eur Respir Monogr 2014; 63: 42-63 Year: 2014 Impact of aspiration pneumonia in community-acquired pneumonia and healthcare-associated pneumonia Source: Annual Congress 2012 - CT findings: educational posters Year: 2012 Analysis of mortality from community-acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 376s Year: 2006 Japanese guidelines for the management of community-acquired pneumonia: differential diagnosis of atypical pneumonia and bacterial pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 374s Year: 2006 Bacterial community-acquired pneumonia Source: Eur Respir Monogr 2014; 66: 98-111 Year: 2014 Legionnaire pneumonia with bacteremic co-infection Source: Annual Congress 2009 - Mechanisms of infection: what's new? Year: 2009